Skip to main content
Premium Trial:

Request an Annual Quote

Sigma-Aldrich, Proteome Sciences Lock in Distribution Deal

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Proteome Sciences said today that it has struck a non-exclusive license agreement with Sigma-Aldrich enabling Sigma to continue selling the ProteoPrep kits in Europe, Japan, and Australia.

The agreement gives Proteome a signing fee and royalties on all eleven of its ProteoPrep kits sold in the three regions. It also covers all future products sold under the ProteoPrep trademark that contain chemicals and reagents for the disruption of cells, tissues, or other biological material and the extraction of biological molecules like proteins, lipids, and carbohydrates.

The trademark also covers methods and processes relating to assays for diagnosing diseases and chemical markers that disrupt cells, tissues, or other materials for determining drug targets and proteins and peptides, the company said.

Further financial terms of the agreement were not disclosed.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.